Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Search content at Oregon Health & Science University
Home
Profiles
Research units
Core Facilities
Publications
Does Anticoagulation in Eisenmenger Syndrome Impact Long-term Survival?
Julio Sandoval
, Luis E. Santos
, Julio Córdova
, Tomás Pulido
, Gerardo Gutiérrez
, Edgar Bautista
, Maria Luisa Martinez Guerra
, Héctor Peña
,
Craig S. Broberg
Knight Cardiovascular Institute
Research output
:
Contribution to journal
›
Article
›
peer-review
48
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Does Anticoagulation in Eisenmenger Syndrome Impact Long-term Survival?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Long-term Survival
100%
Anticoagulation
100%
Eisenmenger Syndrome
100%
Hazard Ratio
25%
Eisenmenger Physiology
16%
Functional Data
8%
Echocardiographic
8%
Catheterization
8%
Retrospective Cohort Study
8%
Non-survivors
8%
Survivors
8%
Bleeding Complications
8%
Kaplan-Meier Method
8%
Log-rank Test
8%
Prognostic Factors
8%
Fatality
8%
Atrial Septal Defect
8%
Primary Prevention
8%
Anticoagulated
8%
Hemoptysis
8%
Anticoagulant Therapy
8%
Hemoglobin
8%
New York Heart Association Class
8%
Vascular Thrombosis
8%
Oxygen Saturation
8%
Prognostic Survival
8%
Survival Disparities
8%
Mean Corpuscular Volume
8%
Baseline Variables
8%
Pulmonary Vascular
8%
Haemodynamic Data
8%
Baseline Evaluation
8%
Failure Hazard
8%
Right Heart Failure
8%
Preventable Adverse Events
8%
Cohort Mortality
8%
Tertiary Referral Hospital
8%
Differences between Groups
8%
Medicine and Dentistry
Long Term Survival
100%
Anticoagulation
100%
Eisenmenger's Syndrome
100%
Hazard Ratio
25%
Patient Referral
16%
Physiology
16%
Atrial Septal Defect
8%
Bleeding
8%
Catheterization
8%
Retrospective Cohort Study
8%
Thrombosis
8%
Hemodynamic
8%
Kaplan Meier Method
8%
Log Rank Test
8%
Prognostic Factor
8%
Identified Patient
8%
Hemoptysis
8%
Anticoagulant Therapy
8%
New York Heart Association Class
8%
Fatality
8%
Primary Prevention
8%
Oxygen Saturation
8%
Hemoglobins
8%
Mean Corpuscular Volume
8%
Heart Right Ventricle Failure
8%
Adverse Event
8%